These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34656296)

  • 1. Meta-Analysis Comparing the Effect of Rivaroxaban Versus Vitamin K Antagonists for Treatment of Left Ventricular Thrombi.
    Saleh Y; Al-Abcha A; Abdelkarim O; Elwany M; Abdelfattah OM; Abdelnabi M; Almaghraby A
    Am J Cardiol; 2021 Dec; 161():123-125. PubMed ID: 34656296
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of left ventricular thrombus by rivaroxaban.
    Padilla Pérez M; Salas Bravo D; Garcelán Trigo JA; Vazquez Ruiz de Castroviejo E; Torres Llergo J; Lozano Cabezas C; Fernández Guerrero JC
    Future Cardiol; 2014 May; 10(3):333-6. PubMed ID: 24976470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of rivaroxaban in left ventricular thrombi.
    Abdelnaby M; Almaghraby A; Abdelkarim O; Saleh Y; Hammad B; Badran H
    Anatol J Cardiol; 2019 Jan; 21(1):47-50. PubMed ID: 30587707
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Chen ST; Hellkamp AS; Becker RC; Berkowitz SD; Breithardt G; Fox KAA; Hacke W; Halperin JL; Hankey GJ; Mahaffey KW; Nessel CC; Piccini JP; Singer DE; Patel MR
    Am J Cardiol; 2017 Nov; 120(10):1837-1840. PubMed ID: 28886856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin for Patients With Left Ventricular Thrombus: A Systematic Review and Meta-Analysis.
    Gue YX; Spinthakis N; Egred M; Gorog DA; Farag M
    Am J Cardiol; 2021 Mar; 142():147-151. PubMed ID: 33359200
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombi: A Systematic Review.
    Sedhom R; Abdelmaseeh P; Megaly M; Asinger R
    Am J Med; 2020 Nov; 133(11):1266-1273.e6. PubMed ID: 32565258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reccurent thrombus in the gigantic left atrium during effective anticoagulant therapy: case report.
    Masarova L; Novak J; Pesl M; Ondrasek J; Semenka J; Simarova E; Panovsky R
    BMC Cardiovasc Disord; 2020 Feb; 20(1):86. PubMed ID: 32085730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY; Hammerstingl C; Marin F; Cappato R; Meng IL; Kirsch B; Morandi E; van Eickels M; Cohen A
    Am Heart J; 2015 Apr; 169(4):464-71.e2. PubMed ID: 25819852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
    Lin C; Quan J; Bao Y; Hua W; Ke M; Zhang N; Jin Q; Xie Y; Wei Y; Ling T; Pan W; Wu L; Xie Y
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):658-663. PubMed ID: 31975470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial.
    Leef GC; Hellkamp AS; Patel MR; Becker RC; Berkowitz SD; Breithardt G; Halperin JL; Hankey GJ; Hacke W; Nessel CC; Singer DE; Fox KAA; Mahaffey KW; Piccini JP
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28615214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality.
    Esteve-Pastor MA; Orenes-Piñero E; Roldán V; Lacunza-Ruiz J; Valdés M; Marín F
    Cardiol J; 2018; 25(1):151-154. PubMed ID: 29512103
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series.
    Smetana KS; Dunne J; Parrott K; Davis GA; Collier ACS; Covell M; Smyth S
    J Thromb Thrombolysis; 2017 Nov; 44(4):519-524. PubMed ID: 28948507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serpentine-like right atrial mass and fulminant bilateral pulmonary embolism during treatment with rivaroxaban.
    Mayr A; Klug G; Greulich S; Metzler B; Feuchtner G
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):1001-2. PubMed ID: 26939567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily 10 mg rivaroxaban as a therapy for ventricular thrombus related to left ventricular non-compaction cardiomyopathy: A case report.
    Sun H; Zhao Q; Wang Y; Lakin R; Feng H; Fan X; Luo H; Gao D; Liu L; He Y; Yang P
    Medicine (Baltimore); 2018 Jan; 97(4):e9670. PubMed ID: 29369185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Resolution of a Large Left Ventricular Thrombus with Rivaroxaban Therapy after Acute Myocardial Infarction.
    Bhatnagar UB; Rezkalla J; Sethi P; Stys A
    S D Med; 2018 Feb; 71(2):62-63. PubMed ID: 29990412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Rivaroxaban a Safe Choice for Apical Thrombus in Atrial Fibrillation Patients? A Case Report.
    Aydin F; Turgay Yildirim O; Huseyinoglu Aydin A; Dagtekin E; Aksit E
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e203-e205. PubMed ID: 29735275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban for Left Ventricular Thrombus.
    Yassin AS; Abubakar H; Mishra T; Adam O; Hartman M; Pahuja M; Shokr M
    Am J Ther; 2019; 26(4):e511-e515. PubMed ID: 29420319
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of Oral Xa Inhibitor for Management of Ischemic Stroke Associated with Thrombosis in the Pulmonary Vein Stump after Lung Resection.
    Amemiya T; Shono T; Yamagami K; Takagishi S; Toma H; Kobarai T; Eguchi T; Hirota I
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104321. PubMed ID: 31422005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial.
    Korjian S; Braunwald E; Daaboul Y; Verheugt F; Bode C; Tendera M; Jain P; Plotnikov A; Burton P; Gibson CM
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):186-193. PubMed ID: 29249166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban plus Percutaneous catheter-directed treatment for a patient with massive pulmonary embolism and colporrhagia.
    Wang W
    Am J Emerg Med; 2018 Aug; 36(8):1522.e5-1522.e7. PubMed ID: 29709396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.